Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 8

1.

Phase I clinical trial of i.v. ascorbic acid in advanced malignancy.

Hoffer LJ, Levine M, Assouline S, Melnychuk D, Padayatty SJ, Rosadiuk K, Rousseau C, Robitaille L, Miller WH Jr.

Ann Oncol. 2008 Nov;19(11):1969-74. doi: 10.1093/annonc/mdn377. Epub 2008 Jun 9. Erratum in: Ann Oncol. 2008 Dec;19(12):2095.

PMID:
18544557
2.

High-dose vitamin C (ascorbic acid) therapy in the treatment of patients with advanced cancer.

Ohno S, Ohno Y, Suzuki N, Soma G, Inoue M.

Anticancer Res. 2009 Mar;29(3):809-15. Review.

3.

[Vitamin C in complementary oncology--update 2009].

Gröber U.

Med Monatsschr Pharm. 2009 Jul;32(7):263-7. Review. German.

PMID:
19731754
4.

Orthomolecular oncology review: ascorbic acid and cancer 25 years later.

González MJ, Miranda-Massari JR, Mora EM, Guzmán A, Riordan NH, Riordan HD, Casciari JJ, Jackson JA, Román-Franco A.

Integr Cancer Ther. 2005 Mar;4(1):32-44. Review.

PMID:
15695476
5.

Rituximab: a review of its use in non-Hodgkin's lymphoma and chronic lymphocytic leukaemia.

Plosker GL, Figgitt DP.

Drugs. 2003;63(8):803-43. Review.

PMID:
12662126
6.

Antioxidant vitamins in the prevention of cardiovascular disease. The epidemiological evidence.

Price JE, Fowkes FG.

Eur Heart J. 1997 May;18(5):719-27. Review. No abstract available.

PMID:
9152642
7.

Pharmacokinetic perspectives on megadoses of ascorbic acid.

Blanchard J, Tozer TN, Rowland M.

Am J Clin Nutr. 1997 Nov;66(5):1165-71. Review.

PMID:
9356534
8.

Ascorbic acid in the prevention and treatment of cancer.

Mata AM, Carvalho RM, Alencar MV, Cavalcante AA, Silva BB.

Rev Assoc Med Bras (1992). 2016 Oct;62(7):680-686. doi: 10.1590/1806-9282.62.07.680. Review.

Supplemental Content

Support Center